Cargando…
Lessons learned from the use of COVID-19 convalescent plasma at Kaiser Permanente
BACKGROUND: In April 2020, the Mayo Clinic helped establish the US Food and Drug Administration Expanded Access Protocol for COVID-19 (coronavirus disease 2019) convalescent plasma (CCP). The effectiveness of CCP in the published literature is contradictory because some retrospective studies showed...
Autores principales: | Tse, Kevin, Chen, Qiaoling, Padilla, Ariadna, Martinez, Kenneth, Salazar, Alejandra, Aidikoff, Jennifer, Soliven, Stephanie, Sintef, Ann, Palmer-Toy, Darryl, Platz, Brian, Shafi, Hedyeh, Zemek, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396439/ https://www.ncbi.nlm.nih.gov/pubmed/36051399 http://dx.doi.org/10.1016/j.jacig.2022.07.003 |
Ejemplares similares
-
Introduction of Network-Based Healthcare at Kaiser Permanente
por: Rompen, Lonneke, et al.
Publicado: (2020) -
Is the Kaiser Permanente model superior in terms of clinical integration?: a comparative study of Kaiser Permanente, Northern California and the Danish healthcare system
por: Strandberg-Larsen, Martin, et al.
Publicado: (2010) -
A retrospective analysis of health systems in Denmark and Kaiser Permanente
por: Frølich, Anne, et al.
Publicado: (2008) -
Kaiser Permanente Northern California sepsis mortality reduction initiative
por: Crawford, B, et al.
Publicado: (2012) -
Kaiser Permanente Vaccine Study Center: Highlights of 2009–2012
por: Baxter, Roger, et al.
Publicado: (2013)